Entities / Company
Olema Pharmaceuticals (United States).
company in San Francisco, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 17
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Olema Pharmaceuticals plans to present mature data on the Palazestrant/ribociclib combination study at ESMO 2025.Some support1 report
-
Olema Pharmaceuticals, headquartered in California, showed potential for a short-term stock rebound on August 13, 2025.Some support1 report
-
Pfizer announced it will supply atirmociclib for a study in collaboration with Olema Pharmaceuticals.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Olema Pharmaceuticals (United States) this week
News at the entities that move Olema Pharmaceuticals (United States) most-
AstraZeneca OperationalAstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Moves Olema Pharmaceuticals (United States)
-
Stifel Mentioned togetherChina and Stifel are currently top suppliers in the critical minerals market, with their market actions showing a preference for producers located outside of China.Moves Olema Pharmaceuticals (United States)
-
MarketBeat Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Olema Pharmaceuticals (United States)
-
San Francisco Shared contextLee Jae Myung met with a community in San Francisco and stated his goal to improve voting access in China.Moves Olema Pharmaceuticals (United States)
-
Cambridge Shared contextA book featuring Alice Hoffman is set in Cambridge during the 1950s.Moves Olema Pharmaceuticals (United States)
-
Nasdaq Shared contextAppLovin stock is traded on Nasdaq, and both AppLovin and Trade Desk operate in the competitive digital advertising technology landscape.Moves Olema Pharmaceuticals (United States)
Connections
The 6 strongest of 17, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
AstraZeneca Operational
AstraZeneca's trial failures impact investor sentiment for Olema Pharmaceuticals, indicating market competition.
-
Stifel Mentioned together
Stifel provided market coverage for Olema, including a price target reduction based on clinical trial outcomes.
-
MarketBeat Mentioned together
MarketBeat covers Olema Pharmaceuticals by reporting its stock consensus ratings.
-
San Francisco Shared context
Olema Pharmaceuticals maintains its headquarters and conducts financial reporting operations in San Francisco.
-
Cambridge Shared context
Olema Pharmaceuticals maintains an operational presence within the city of Cambridge.
-
Nasdaq Shared context
Olema Pharmaceuticals lists its shares for trading on the Nasdaq exchange.
History
Events by the month they beganSeptember 2026
1 eventJune 2026
3 events- Olema Pharmaceuticals plans to present mature data on the Palazestrant/ribociclib combination study at ESMO 2025.
- Olema Pharmaceuticals, headquartered in California, showed potential for a short-term stock rebound on August 13, 2025.
- Pfizer announced it will supply atirmociclib for a study in collaboration with Olema Pharmaceuticals.